Cresco Labs to Acquire Tryke Companies

Total Page:16

File Type:pdf, Size:1020Kb

Cresco Labs to Acquire Tryke Companies NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE U.S. CRESCO LABS TO ACQUIRE TRYKE COMPANIES INCLUDING THE REEF DISPENSARY PORTFOLIO – CONSISTENT WITH STATED PLAN TO ESTABLISH MARKET LEADING POSITIONS IN BOTH NEVADA AND ARIZONA AND BUILD BRAND AND WHOLESALE CAPABILITIES ANNOUNCES C$73.5 MILLION UNDERWRITTEN PUBLIC UNIT OFFERING • Tryke generated US$70.4 million in Revenue and US$24.6 million in EBITDA in fiscal 20181, making it one of the highest grossing and most profitable private cannabis companies in the U.S. market. • Nevada is one of the largest and fastest growing cannabis markets in the U.S. with 2019 sales estimates of up to US$940 million2; Arizona is one of the largest and fastest growing medical-only markets with estimated 2019 sales of up to US$760 million2. • Tryke has established six of the best-positioned retail locations in Nevada and Arizona, including the iconic Reef Dispensary located adjacent to the Las Vegas Strip – which has produced over US$65 million in revenue since 2015 – and five additional operating locations in North Las Vegas, Sparks and Phoenix, AZ. Tryke’s North Las Vegas location boasts the highest known daily ticket count in the state of Nevada at 2,3003. • Adds 17,000 lb. per year in strategically-located cultivation capacity along with 1,320 lb. per year of processing capacity. • Includes one of eight cultivation licenses recently awarded in Utah. • Total consideration of US$282.5 million (subject to certain adjustments), which includes US$30M in real estate assets4. CHICAGO, IL – September 16, 2019 – Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced a significant expansion of its presence in Nevada and Arizona through the signing of a purchase agreement to acquire certain assets (the “Transaction”) from Tryke Companies (“Tryke”), a vertically integrated seed-to-sale cannabis company, including six prime Reef Dispensary locations in Nevada and Arizona, expanded licensed cultivation and process capacity in Las Vegas and Phoenix and entry into the Utah market. The Company has prepared a summary presentation describing the Transaction, which can be found on their investor website at investors.crescolabs.com or at the following link: https://s22.q4cdn.com/545881950/files/doc_presentations/2019/09/cresco-labs-tryke-companies.pdf 1 Based on unaudited financial information (U.S. GAAP) provided by Tryke Companies 2 2019 Marijuana Business Factbook 3 August 2019 – Tryke Companies 4 Tryke Companies estimates Cresco Labs Page 2 of 7 Highlights Fulfills Cresco Labs’ stated objective to rapidly solidify leadership positions in large, culturally-influential U.S. jurisdictions – The Company is currently active in 11 states accounting for 70% of the U.S. population. Its Phase II plan is to continue building meaningful leadership positions in each of these jurisdictions. – The Transaction is expected to give Cresco approximately 8.11% market share in Nevada5, estimated to be top 3 among all operators, a more than 300% increase in the Company’s market share in Arizona, along with access to a 12th state – Utah – via Tryke’s recent receipt of one of eight cultivation licenses in the state. – Las Vegas is one of the most influential consumer recreational markets in the U.S., hosting roughly 42 million tourists per year6 focused almost exclusively on the 4 miles of the Las Vegas Strip. As a result, Las Vegas has a proven national and international reach for companies seeking to build successful brands. – Arizona is one of the largest medical-only markets in the U.S. with more than 210,000 registered patients7 and the majority of the state’s population is densely located in Phoenix, the 5th most populous city in the U.S. Arizona is expected to have an initiative on the 2020 ballot to legalize adult- use sales2. Adds a portfolio of some of the most visible and successful retail locations in the U.S. legal cannabis industry as well as the Tryke in-house brand portfolio – The Transaction adds four (4) Reef Dispensary locations in Nevada in the cities of Las Vegas (2), Sparks and Sun Valley. – The Transaction adds two (2) Reef Dispensaries in Arizona in Phoenix and Phoenix Southeast Valley. – Tryke’s flagship Reef Dispensary in Las Vegas is the closest dispensary to the heart of the Las Vegas Strip. To management’s knowledge, on its current 4,800 square foot footprint, it is already one of the highest-grossing dispensaries in the world, with the current highest known grossing dispensary in the world, right across the street. There is no intersection in the world generating more regulated cannabis revenue annually than the intersection of Western Ave. and Desert Inn Rd. in Las Vegas. – The Reef Dispensary in North Las Vegas generated US$14.5 million in revenue in the year-to-date period to August 31, 20191. This location also averaged over 2,300 tickets per day in August 2019, giving it the highest known monthly count in the state. – Tryke’s in-house suite of branded products is one of the most successful and recognizable lines of products in the Nevada market currently. Expanded Cultivation and Processing Capacity in Nevada and Arizona – will support the introduction of Cresco Labs’ full suite of branded products in each state and enable wholesale operations – Cresco Labs currently sells the well-known and successful Mindy’s Edibles line in Nevada. Mindy’s has been one of the top 3 selling edibles in Nevada in 2019.8 The Transaction will enable the Company to accelerate its plans to introduce a full suite of Cresco Labs products into Nevada. 5 Average market share for January – June 2019 as per https://tax.nv.gov/Publications/Marijuana_Statistics_and_Reports/ 6 Las Vegas Convention and Visitors Authority 7 Arizona Department of Health Services 8 Headset and Cowen and Company Cresco Labs Page 3 of 7 – The Tryke Las Vegas Strip location covers a total of 165,000 square feet, which includes the flagship 4,800 square foot Reef Dispensary as well as 160,200 square feet of cultivation, processing and ancillary space (~20,000 sf under canopy). – Includes 27,000 square feet of cultivation and processing capacity in Phoenix, Arizona. – Tryke also has a cultivation license attached to a 12 acre parcel in Spanish Springs, Nevada with a plan to open the 17,000 lb. per year Phase I build-out during 2020. Management Commentary: Cresco Labs CEO and Co-founder Charlie Bachtell commented, “We have been very clear with the market that we have entered the second chapter of the Cresco Labs story as we position the Company to lead in the middle two verticals of the value chain – brands and wholesale distribution. With significant in-state populations and tourist traffic, Nevada and Arizona were key near-term targets for expansion. Creating the most strategic geographic footprint in the U.S. cannabis industry is not just about the number of states you operate in. Rather, our thesis for success in establishing a normalized and professionalized cannabis industry as well as providing the greatest ROIC for our shareholders calls for us to leverage our existing operations in states of significance to rapidly attain material and meaningful market-leading positions. This Transaction meets every point in our ROIC framework. It accelerates top-line growth, enables efficiencies across our network through the addition of one of the most impressive operating teams in the country and brings a pipeline of high return projects that we expect to execute on at a measured pace over the next several years.” Mr. Bachtell continued, “This Transaction adds six strategically-placed retail locations serving both in-state and tourist traffic, as well as robust supporting cultivation and processing infrastructure and significant expansion opportunities. The Las Vegas Strip has immense value from a sales and brand development perspective. The Strip is home to some of the most iconic entertainment and recreational properties in the world – and is probably one of only two spots in the country where tens of millions of people per year congregate within a very concentrated footprint with recreation in mind. This inimitable exposure opens the opportunity to continue to generate above average revenue and sustainable margins for operators as well as brand visibility that resonates on a national level. We utilize a strategic retail presence to assist in the achievement of our corporate objective to win the middle two portions of the value chain – brands and distribution. At the industry’s current state of development, retail is a vital link between customers and brands in this emerging legal industry. We expect that this Transaction will both accelerate our near- term growth trajectory and further advance Cresco Labs towards our goal of being the most important company in the cannabis industry.” “This Transaction is a perfect complement to our organic branded product portfolio and the distribution portfolio we are acquiring through Origin House, giving Cresco Labs positions in the key middle portion of the value chain in the most exciting consumer markets in the country. Tryke has proven itself to be one of the top operators in the U.S. and we look forward to welcoming Tryke’s seasoned team to Cresco Labs to work on growth and optimization initiatives together,” said Cresco Labs President and Co-founder Joe Caltabiano. “Tryke’s team has deep experience in and connection to the highly regulated Nevada and Arizona markets and is in the midst of bringing that experience to the new Utah medical cannabis market. They have also done an outstanding job of developing relationships with key social influencers such as Wiz Khalifa, which has enabled the company to become the sole distributor of Khalifa Kush products in Nevada and Arizona, and they have also developed strong brand loyalty for the Tryke suite of products.
Recommended publications
  • CRESCO LABS INC. November 30, 2018 LISTING STATEMENT
    CRESCO LABS INC. November 30, 2018 LISTING STATEMENT - FORM 2A IN CONNECTION WITH THE LISTING OF THE SHARES OF CRESCO LABS INC., THE ENTITY FORMERLY KNOWN AS RANDSBURG INTERNATIONAL GOLD CORP., AFTER THE REVERSE TAKEOVER BY CRESCO LABS, LLC MARIJUANA IS ILLEGAL UNDER U.S. FEDERAL LAW AND THE ENFORCEMENT OF RELEVANT LAWS IS A SIGNIFICANT RISK. Cresco Labs Inc. indirectly holds all the voting interests and an approximate 53% equity interest in Cresco Labs, LLC, the entity through which all of the operating subsidiaries of Cresco Labs, LLC are held. Shareholders are cautioned that at this time, the outstanding Subordinate Voting Shares and Proportionate Voting Shares does not represent all of the equity interest in Cresco Labs, LLC. Cresco Labs Inc. derives a substantial portion of its revenues from the cannabis industry in certain states of the United States, which industry is illegal under United States federal law. Cresco Labs Inc. is indirectly involved (through its licensed subsidiaries) in the cannabis industry in the United States where local state laws permit such activities. Currently, its subsidiaries are directly engaged in the manufacturing, possession, use, sale or distribution of cannabis in the recreational and/or medicinal cannabis marketplace in the States of Illinois, Pennsylvania, Ohio, Nevada, Arizona and California and will begin such activities in New York, Massachusetts and Maryland in the near term. The United States federal government regulates drugs through the Controlled Substances Act, 21 U.S.C. § 811 (the "CSA"), which places controlled substances, including cannabis, in a schedule. Cannabis is classified as a Schedule I drug.
    [Show full text]
  • CCB 2021 0322.Pdf
    INDEMAND JOBS: Here are the 10 hottest well-paying careers in Illinois. PAGE 12 CONVENTIONS: What Chicago must do to win them back. PAGE 3 CHICAGOBUSINESS.COM | MARCH 22, 2021 | $3.50 MANUFACTURING As the ‘engine Socially conscious investing gains currency as investors seek to improve sustainability of the economy’ and bene t the social good while still making money. PAGE 15 heats up again, tech advances are accelerating ahead of a lagging labor FACTORIES FORWARD force. PAGE 15 FACTORIES FORWARD FIND THE COMPLETE SERIES ONLINE ChicagoBusiness.com/CrainsForum ZAC OSGOOD ZAC How Chicago became Herd immunity: the Silicon Valley of pot Kayvan Khalatbari, a cannabis A moving target Early obstacles helped consultant from Denver who turn local marijuana advised Cresco on its original li- Threshold for stopping COVID is higher in some areas cense application. companies into giants In the six years since Illinois BY STEPHANIE GOLDBERG issued its rst licenses to grow MINDING THE GAP: Why so many health care workers are BY JOHN PLETZ and sell marijuana for medical As COVID-19 inoculations use, GTI, Cresco, Verano and accelerate, a weary public waits still unvaccinated. PAGE 3 Call Chicago the capital of Big privately held PharmaCann have anxiously for vaccines to reach 70 Weed. emerged as industry giants, win- BOEHM R. JOHN percent of the population, a level tration in areas that have been e city is home to three of the ning or acquiring licenses across Cresco CEO Charlie Bachtell widely associated with “herd im- hit harder during the pandemic. ve biggest public companies in the country as legalization took munity.” In other words, vaccinating any the United States that grow and o .
    [Show full text]
  • Cresco Labs Announces Opening of Sixth Sunnyside in Illinois and First Cannabis Dispensary in Danville
    CRESCO LABS ANNOUNCES OPENING OF SIXTH SUNNYSIDE IN ILLINOIS AND FIRST CANNABIS DISPENSARY IN DANVILLE Cresco Labs increases national retail footprint to 16 operating stores and widens Sunnyside’s reach in eastern Illinois Cresco Labs’ Sunnyside dispensary in Danville is the first adult-use only store in eastern Illinois CHICAGO – May 27, 2020 — Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the opening of its sixth Illinois dispensary located at 369 Lynch Dr. in the city of Danville. As the first cannabis retail store to open in eastern Illinois, near the Indiana border, Sunnyside Danville is ideally positioned to introduce its portfolio of owned brands to the tens of thousands of people living in the region. “We’re excited to bring the Sunnyside retail experience and introduce our house of brands to people living in eastern Illinois. This is our sixth store in Illinois and with additional cultivation from our recent expansion coming online throughout Q3, we are set to generate significant operating leverage and demonstrate the value of going deep,” said Charlie Bachtell, Cresco Labs’ CEO and Co-founder. Cresco completely renovated the adult-use only Danville location to showcase the Sunnyside retail concept. Designed to offer an educational and welcoming shopping experience with bright light, natural wood tones and sunny accents, the store has 4,800 square feet of space with over 10 points of sale and products divided by form and function. Sunnyside Danville’s store hours are 10:00 AM to 9:00 PM daily, seven days a week starting May 27th.
    [Show full text]
  • CRESCO LABS OHIO LLC Application ID 470
    Ohio Medical Marijuana Dispensary Application CRESCO LABS OHIO LLC Application ID 470 Demographic Information(Business Contact) A-1.1 Business Name, as it appears on the Applicant’s certificate of incorporation, charter, bylaws, partnership agreement or other legal business formation documents Cresco Labs Ohio LLC A-1.2 Other trade names and DBA (doing business as) names No response provided by applicant A-1.3 Business Street Address 6545 Market Avenue North, STE 100 A-1.4 City North Canton A-1.5 State OH A-1.6 Zip Code 44721 A-1.7 Phone 6144408589 A-1.8 Email [email protected] Demographic Information(Primary Contact/Registered Agent) A-2.1 Please select: Primary Contact, or Registered Agent for this Application PRIMARY CONTACT A-2.2 First Name Christopher A-2.3 Middle Name Thomas A-2.4 Last Name Schrimpf A-2.5 Street Address 113 South Ardmore A-2.6 City Bexley A-2.7 State OH A-2.8 Zip Code 43209 A-2.9 Phone 6144408589 A-2.10 Email [email protected] Demographic Information(Applicant Organization and Tax Status) A-3.1 Select One Limited Liability Company A-3.1A If other, explain No response provided by applicant A-3.2 State of Incorporation or Registration OH A-3.3 Date of Formation 05/22/2017 A-3.4 Business Name on Formation Documents Cresco Labs Ohio, LLC A-3.5 Federal Employer ID number This response has been entirely redacted A-3.6 Ohio Unemployment Compensation Account Number No response provided by applicant A-3.7 Ohio Department of Taxation Number (if Applicant is currently doing business in Ohio) No response provided by applicant A-3.8 Ohio Workers’ Compensation Policy Number (if Applicant is currently doing business in Ohio) No response provided by applicant A-3.9 The Applicant attests that workers’ compensation insurance will be obtained by the time the State of Ohio Board of Pharmacy determines the Applicant to be operational under the Act and regulations.
    [Show full text]
  • Q4 2019 Your Cannabis Investment Resource
    THE CANNIN REPORT | Q4 Q4 2019 Your Cannabis investment resource. THE CANNIN REPORT | Q3 Risks Disclosures If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution. The Department of Treasury recently issued guidance noting: “[T]he Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana. Many states impose and enforce similar prohibitions. Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized the certain marijuana-related activity.” Fundamental Analysis Sections p. 11 | CuraLeaf Holdings Inc. p. 15 | Planet 13 Holdings Inc. p. 18 | MJardin Group p. 21 | Innovative Industrial Properties p. 25 | KushCo Holdings Inc. p. 29 | Harvest Health and Recreation Inc. p. 32 | Green Thumb Industries p. 37 | MedMen p. 41 | TILT Holdings p. 45 | Acreage Holdings p. 49 | Trulieve Cannabis Corp. p. 53 | Cresco Labs Inc. 9 THE CANNIN REPORT | Q3 Cresco Labs Inc. Fundamentals Profile: HQ: Chicago, IL, USA Founded: 1990 Facilities: Chicago, Joliet, Lincoln, Fall River, Salome, Las Vegas, San Luis Obispo, Mendota, others Symbol: CRLBF (OTC); CL (CSE) Focus: Strong As a top-quality cannabis producer, processor and retailer operating in seven US states, the company focuses on entering highly regulated markets with excessive demand potential and high barriers to entry. Cresco has elevated everyday cannabis through its THC-forward products available in flower, vape pens, and multiple forms of extracts. Cresco plans to leverage the success in Illinois, Pennsylvania, Ohio, Nevada, California, and Arizona to expand into legalized cannabis markets in other states, while focusing on compliance, control, efficiency, and product performance in the medicinal or adult-use cannabis industry.
    [Show full text]
  • 2021 Environmental, Social and Governance Report
    2021 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT PUBLISHED JUNE 7, 2021 2021 IIP ESG REPORT LETTER FROM OUR EXECUTIVE CHAIRMAN We are delighted to present to you Innovative Industrial Properties, Inc.’s (IIP) inaugural Environmental, Social and Governance Report. From its founding in December 2016, IIP has focused on supporting the high-growth, rapidly evolving regulated cannabis industry in the United States. We recognized an opportunity to apply our team’s extensive real estate experience to this new sector and help bring the benefits that our capital provides to as wide an audience as possible. At the same time, we recognized that our role extends beyond simply being an investor in real estate. As a team, we are also committed to sound environmental management, collaborative community engagement, and strong corporate governance principles, evolving and strengthening our actions in these areas as we grow as a company. Most importantly, we recognize that our operations, and those of our tenants, have the potential to transform thousands of lives in the communities where our properties are located. Many of these communities have experienced significant hardships, most notably losses in jobs and commerce due to industry disruption and migration to other geographies. However, together with our tenant partners, we have demonstrated the ability to bring back good jobs, economic activity and much needed benefits to the people of these communities, in addition to key tax revenues that drive reinvigoration of local services, schools and healthcare. We are excited to bring even more transparency to how we operate with this report. While we are in the early stages of reporting on our environmental, social and governance journey, we are committed to improving the disclosures we make year over year and exploring additional opportunities where we can make a positive, lasting, meaningful impact for all of our stakeholders: our stockholders, tenant partners, employees and communities.
    [Show full text]
  • Annual Information Form
    Annual Information Form For the year ended December 31, 2017 Dated March 11, 2019 TABLE OF CONTENTS GENERAL ................................................................................................................................................................. 1 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION ............................. 1 MARKET DATA AND INDUSTRY FORECASTS ............................................................................................... 2 CORPORATE STRUCTURE .................................................................................................................................. 2 GENERAL DEVELOPMENT OF THE BUSINESS ............................................................................................. 2 DESCRIPTION OF THE BUSINESS ................................................................................................................... 10 RISK FACTORS ..................................................................................................................................................... 58 DIVIDENDS AND DISTRIBUTIONS ................................................................................................................... 84 DESCRIPTION OF CAPITAL STRUCTURE..................................................................................................... 84 MARKET FOR SECURITIES ............................................................................................................................. 102 CONSOLIDATED CAPITALIZATION ............................................................................................................
    [Show full text]
  • The Time Is Now for U.S. Cannabis January 25, 2021
    Equity Research U.S. Cannabis Industry January The Time is Now for U.S. Cannabis January 25, 2021 Given an attractive growth outlook for both medical and recreational markets in the U.S., improved execution by operators, healthier balance sheets and current Viridian Capital Advisors valuation trends for certain companies, we believe now is an attractive time to invest (or reinvest) in the U.S. cannabis market. The more attractive companies are those www.viridianca.com with established profitable and growing businesses in core markets which are poised for additional state expansion, but are more overlooked by analysts and investors. Jonathan DeCourcey 2020 was an evolutionary year of development for cannabis. In Q1/20, the industry Director Equity Research was nearly a year into a valuation decline which began in Q2/19 and continued [email protected] through the vape crisis with stock prices hitting a five year low in early March. Things began to change in the early days of COVID- 19, with cannabis companies deemed to (781) 724.6869 be essential businesses. Sales accelerated in legal markets at a time when most other retail industries struggled. With initial sales in Illinois and Michigan, recreational cannabis moved beyond the coasts. Five states passed ballot initiatives in November. Some states openly discussed legalization as a tool to offset economic hardship. Cannabis Investment Thesis Capital markets activity improved late in 2020 with the U.S. becoming the focal point • Visible and Profitable of investment and M&A activity. We expect the upswing to continue as capital is Long-Term Industry Growth becoming less costly for companies on improved investor interest (particularly from institutional investors), and increased debt financings.
    [Show full text]
  • Choice Consolidation Corp. Investor Presentation February 1, 2021
    Choice Consolidation Corp. Investor Presentation February 1, 2021 This document is for information purposes only and should not be considered a recommendation to purchase, sell or hold a security. This document does not constitute an offering memorandum or an offer or solicitation in any province or territory in Canada or other jurisdiction in which an offer or solicitation is not authorized. A copy of the preliminary prospectus dated January 22, 2021 containing important information relating to the securities described in this document has been filed with the securities regulatory authorities in each of the provinces and territories of Canada, except Québec. A copy of the preliminary prospectus, and any amendment, is required to be delivered with this document. The preliminary prospectus is still subject to completion. Copies of the preliminary prospectus may be obtained from www.sedar.com. There will not be any sale or any acceptance of an offer to buy the securities until a receipt for the final prospectus has been issued. No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise. The preliminary prospectus constitutes a public offering of the securities only in those jurisdictions where they may be lawfully offered for sale and, in such jurisdictions, only by persons permitted to sell such securities. This document does not provide full disclosure of all material facts relating to the securities offered. Investors should read the preliminary prospectus, the final prospectus and any amendment for disclosure of those facts, especially risk factors relating to the securities offered, before making an investment decision.
    [Show full text]
  • Building America's Largest Cannabis Company
    BUILDING AMERICA’S LARGEST CANNABIS COMPANY APRIL 2019 DISCLAIMER This presentation contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward- looking statements, including but not limited to those risks discussed under "Risk Factors" in the company’s CSE Listing Statement filed with SEDAR; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco’s shares, nor as to the Company’s financial performance in future financial periods.
    [Show full text]
  • Renewal Application – Cresco HHH
    Massachusetts Cannabis Control Commission Marijuana Product Manufacturer General Information: License Number: MP281361 Original Issued Date: 04/12/2019 Issued Date: 05/13/2021 Expiration Date: 06/08/2022 ABOUT THE MARIJUANA ESTABLISHMENT Business Legal Name: Cresco HHH, LLC Phone Number: 774-226-7749 Email Address: [email protected] Business Address 1: 100 Summer Street Business Address 2: Business City: Boston Business State: MA Business Zip Code: 02110 Mailing Address 1: 1 West St. Mailing Address 2: Mailing City: Fall River Mailing State: MA Mailing Zip Code: 02720 CERTIFIED DISADVANTAGED BUSINESS ENTERPRISES (DBES) Certifed Disadvantaged Business Enterprises (DBEs): Not a DBE PRIORITY APPLICANT Priority Applicant: yes Priority Applicant Type: RMD Priority Economic Empowerment Applicant Certifcation Number: RMD Priority Certifcation Number: RPA201894 RMD INFORMATION Name of RMD: Cresco HHH, LLC Department of Public Health RMD Registration Number: PCR Only Operational and Registration Status: Applied for Certifcate of Registration, decision by DPH is pending To your knowledge, is the existing RMD certifcate of registration in good standing?: yes If no, describe the circumstances below: PERSONS WITH DIRECT OR INDIRECT AUTHORITY Person with Direct or Indirect Authority 1 Percentage Of Ownership: 3.66 Percentage Of Control: 10 Role: Executive / Ofcer Other Role: Chief Executive Ofcer, Co-Founder, Board Member First Name: Charles Last Name: Bachtell Sufx: Gender: Male User Defned Gender: Date generated: 05/24/2021 Page: 1 of 18
    [Show full text]
  • CRESCO LABS OHIO LLC Application ID 617
    Ohio Medical Marijuana Dispensary Application CRESCO LABS OHIO LLC Application ID 617 Demographic Information(Business Contact) A-1.1 Business Name, as it appears on the Applicant’s certificate of incorporation, charter, bylaws, partnership agreement or other legal business formation documents Cresco Labs Ohio LLC A-1.2 Other trade names and DBA (doing business as) names No response provided by applicant A-1.3 Business Street Address 6545 Market Avenue North, STE 100 A-1.4 City North Canton A-1.5 State OH A-1.6 Zip Code 44721 A-1.7 Phone 6144408589 A-1.8 Email [email protected] Demographic Information(Primary Contact/Registered Agent) A-2.1 Please select: Primary Contact, or Registered Agent for this Application PRIMARY CONTACT A-2.2 First Name Christopher A-2.3 Middle Name Thomas A-2.4 Last Name Schrimpf A-2.5 Street Address 113 South Ardmore A-2.6 City Bexley A-2.7 State OH A-2.8 Zip Code 43209 A-2.9 Phone 6144408589 A-2.10 Email [email protected] Demographic Information(Applicant Organization and Tax Status) A-3.1 Select One Limited Liability Company A-3.1A If other, explain No response provided by applicant A-3.2 State of Incorporation or Registration OH A-3.3 Date of Formation 05/22/2017 A-3.4 Business Name on Formation Documents Cresco Labs Ohio, LLC A-3.5 Federal Employer ID number This response has been entirely redacted A-3.6 Ohio Unemployment Compensation Account Number No response provided by applicant A-3.7 Ohio Department of Taxation Number (if Applicant is currently doing business in Ohio) No response provided by applicant A-3.8 Ohio Workers’ Compensation Policy Number (if Applicant is currently doing business in Ohio) No response provided by applicant A-3.9 The Applicant attests that workers’ compensation insurance will be obtained by the time the State of Ohio Board of Pharmacy determines the Applicant to be operational under the Act and regulations.
    [Show full text]